Reports for ACTAVIS PHARMA COMPANY

Company Name

ACTAVIS PHARMA COMPANY

Totals

Shortage reports

13

Actual shortage: 7 (54%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 6 (46%)

Discontinuation Reports

56

To be discontinued: 0 (0%)
Discontinued: 56 (100%)
Reversed: 0 (0%)

Late reports

58 (84%)

Overdue reports

0 (0%)

Showing 21 to 13 of 13

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT ROSUVASTATIN 10MG TABLET Discontinued 2018-10-22 2018-10-22 65157
ACT ROSUVASTATIN 20MG TABLET Discontinued 2018-10-22 2018-10-22 65160
ACT ROSUVASTATIN 20MG TABLET Discontinued 2018-10-22 2018-10-22 65165
ACT ROSUVASTATIN 40MG TABLET Discontinued 2018-10-22 2018-10-22 65168
ACT ROSUVASTATIN 5MG TABLET Discontinued 2018-10-22 2018-10-22 65258
ACT ROSUVASTATIN 5MG TABLET Discontinued 2018-10-22 2018-10-22 65261
ACT ROSUVASTATIN 40MG TABLET Discontinued 2018-10-22 2018-10-22 65275
ACT ROSUVASTATIN 5MG TABLET Discontinued 2018-10-22 2018-10-22 65308
ACT ROSUVASTATIN 10MG TABLET Discontinued 2018-10-22 2018-10-22 65322
ACT ROSUVASTATIN 20MG TABLET Discontinued 2018-10-22 2018-10-22 65325
ACT VALSARTAN 160MG TABLET Discontinued 2018-10-22 2018-10-22 65264
ACT VALSARTAN 320MG TABLET Discontinued 2018-10-22 2018-10-22 65267
ACT VALSARTAN 40MG TABLET Discontinued 2018-10-22 2018-10-22 65272
ACT VALSARTAN 80MG TABLET Discontinued 2018-10-22 2018-12-07 65278
RECLIPSEN 21 Discontinued 2018-11-20 2018-11-20 67254
RECLIPSEN 28 Discontinued 2018-11-20 2018-11-20 67257

Showing 41 to 56 of 56